.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Deloitte
Cipla
Daiichi Sankyo
Mallinckrodt
Fuji
Colorcon
Farmers Insurance
Boehringer Ingelheim
Harvard Business School

Generated: June 29, 2017

DrugPatentWatch Database Preview

Furosemide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for furosemide and what is the scope of furosemide freedom to operate?

Furosemide
is the generic ingredient in two branded drugs marketed by Sun Pharm Inds, Fresenius Kabi Usa, Watson Labs, Abraxis Pharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Astrazeneca, Dava Pharms Inc, Marsam Pharms Llc, Organon Usa Inc, Warner Chilcott, Smith And Nephew, West-ward Pharms Int, Intl Medication, Emcure Pharms Ltd, Watson Labs Teva, Hospira, Wockhardt, Claris, Sandoz, Amneal Pharms Co, Sun Pharm Inds Inc, Sanofi Aventis Us, Kalapharm, Wyeth Ayerst, Superpharm, Us Pharm Holdings, Luitpold, Mylan, Mutual Pharm, Leading Pharma Llc, Igi Labs Inc, and Prinston Inc, and is included in sixty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for furosemide. Sixty-one suppliers are listed for this compound.

Summary for Generic Name: furosemide

Tradenames:2
Patents:1
Applicants:33
NDAs:60
Drug Master File Entries: see list21
Suppliers / Packagers: see list61
Bulk Api Vendors: see list85
Clinical Trials: see list148
Patent Applications: see list7,563
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:furosemide at DailyMed

Pharmacology for Ingredient: furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mutual Pharm
FUROSEMIDE
furosemide
TABLET;ORAL018790-001Nov 29, 1983DISCNNoNo► Subscribe► Subscribe
Warner Chilcott
FUROSEMIDE
furosemide
TABLET;ORAL018419-002Jan 31, 1983DISCNNoNo► Subscribe► Subscribe
Hospira
FUROSEMIDE
furosemide
INJECTABLE;INJECTION075241-001May 28, 1999APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
FUROSEMIDE
furosemide
SOLUTION;ORAL070434-001Apr 22, 1987AARXNoYes► Subscribe► Subscribe
Superpharm
FUROSEMIDE
furosemide
TABLET;ORAL018370-002Jun 26, 1984DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-003Approved Prior to Jan 1, 19824,324,779► Subscribe
Sanofi Aventis Us
LASIX
furosemide
INJECTABLE;INJECTION016363-001Approved Prior to Jan 1, 19824,324,779► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-001Approved Prior to Jan 1, 19824,324,779► Subscribe
Sanofi Aventis Us
LASIX
furosemide
SOLUTION;ORAL017688-001Approved Prior to Jan 1, 19824,324,779► Subscribe
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-002Approved Prior to Jan 1, 19824,324,779► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Covington
Colorcon
Federal Trade Commission
Moodys
Mallinckrodt
Baxter
Argus Health
Chubb
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot